GOSS Stock Price
Gossamer Bio, Inc.
GOSS stock price is $8.91 (-8.76% on the day), giving Gossamer Bio, Inc. a market cap of $54.47M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
GOSS Stock Overview
- Price
- $8.90
- Previous close
- $9.76
- Open
- $9.59
- Market cap
- $54.47M
- P/E ratio
- -0.3
- 52-week range
- $9.10 - $309.60
- 1-year price target
- $82.48
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 27
About Gossamer Bio, Inc.
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GOSS | $8.91 | -8.8% | 360.58K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |